Published in Am J Trop Med Hyg on August 01, 2009
Ecology and evolution as targets: the need for novel eco-evo drugs and strategies to fight antibiotic resistance. Antimicrob Agents Chemother (2011) 1.40
Validation of five-colony pool analysis using multiplex real-time PCR for detection of diarrheagenic Escherichia coli. J Clin Microbiol (2009) 1.16
Amplification and purification of T4-like escherichia coli phages for phage therapy: from laboratory to pilot scale. Appl Environ Microbiol (2013) 0.86
Characterization of Diarrheagenic Antimicrobial Resistant Escherichia coli Isolated From Pediatric Patients in Tehran, Iran. Iran Red Crescent Med J (2014) 0.84
Analysis of quinolone-resistance in commensal and diarrheagenic Escherichia coli isolates from infants in Lima, Peru. Trans R Soc Trop Med Hyg (2013) 0.84
Molecular mechanisms of antibiotic resistance in diarrhoeagenic Escherichia coli isolated from children. Int J Antimicrob Agents (2012) 0.83
Virulence factors and mechanisms of antimicrobial resistance in Shigella strains from periurban areas of Lima (Peru). Int J Med Microbiol (2015) 0.81
Resistance to Fluoroquinolone by a Combination of Efflux and Target Site Mutations in Enteroaggregative Escherichia coli Isolated in Korea. Osong Public Health Res Perspect (2012) 0.80
Diarrheagenic Escherichia coli phylogroups are associated with antibiotic resistance and duration of diarrheal episode. ScientificWorldJournal (2015) 0.79
Pathogenesis of human diffusely adhering Escherichia coli expressing Afa/Dr adhesins (Afa/Dr DAEC): current insights and future challenges. Clin Microbiol Rev (2014) 0.79
Comparative analysis of antimicrobial resistance in enterotoxigenic Escherichia coli isolates from two paediatric cohort studies in Lima, Peru. Trans R Soc Trop Med Hyg (2015) 0.77
Diarrheagenic Escherichia coli in human immunodeficiency virus (HIV) pediatric patients in Lima, Peru. Am J Trop Med Hyg (2010) 0.76
Antimicrobial resistance of bacterial enteropathogens isolated from stools in Madagascar. BMC Infect Dis (2014) 0.76
The commonly-used DNA probe for diffusely-adherent Escherichia coli cross-reacts with a subset of enteroaggregative E. coli. BMC Microbiol (2009) 0.76
Antimicrobial Activity of Lactobacillus spp. Isolated From Fecal Flora of Healthy Breast-Fed Infants Against Diarrheagenic Escherichia coli. Jundishapur J Microbiol (2015) 0.76
Retracted Shiga Toxigenic Escherichia coli in Iranian Pediatric Patients With and Without Diarrhea: O-Serogroups, Virulence Factors and Antimicrobial Resistance Properties. Iran Red Crescent Med J (2015) 0.75
Effects of Selection Pressure and Genetic Association on the Relationship between Antibiotic Resistance and Virulence in Escherichia coli. Antimicrob Agents Chemother (2015) 0.75
Surveillance of Diarrheagenic Escherichia coli Strains Isolated from Diarrhea Cases from Children, Adults and Elderly at Northwest of Mexico. Front Microbiol (2016) 0.75
Highly-resistant E. coli as a common cause of paediatric diarrhoea in India. J Health Popul Nutr (2013) 0.75
Antihypercholesterolemic activity of ethanolic extract of Buchholzia coriacea in rats. Afr Health Sci (2013) 0.75
Case-Case Analysis Using 7 Years of Travelers' Diarrhea Surveillance Data: Preventive and Travel Medicine Applications in Cusco, Peru. Am J Trop Med Hyg (2017) 0.75
Diarrheagenic Escherichia coli. Clin Microbiol Rev (1998) 30.09
WHO estimates of the causes of death in children. Lancet (2005) 18.33
Antimicrobial resistance in developing countries. Part I: recent trends and current status. Lancet Infect Dis (2005) 5.58
Effects of stunting, diarrhoeal disease, and parasitic infection during infancy on cognition in late childhood: a follow-up study. Lancet (2002) 4.90
Differential expression of over 60 chromosomal genes in Escherichia coli by constitutive expression of MarA. J Bacteriol (2000) 3.27
Enteric infections, diarrhea, and their impact on function and development. J Clin Invest (2008) 3.23
Early childhood diarrhea is associated with diminished cognitive function 4 to 7 years later in children in a northeast Brazilian shantytown. Am J Trop Med Hyg (2002) 2.22
Consumer attitudes and use of antibiotics. Emerg Infect Dis (2003) 2.20
Antibiotic prescribing and antibiotic resistance in community practice: retrospective study, 1996-8. BMJ (1999) 2.14
Pathogenesis of enteroaggregative Escherichia coli infection. FEMS Microbiol Lett (2006) 2.13
A millennium update on pediatric diarrheal illness in the developing world. Semin Pediatr Infect Dis (2005) 2.13
Detection of diarrheagenic Escherichia coli by use of melting-curve analysis and real-time multiplex PCR. J Clin Microbiol (2008) 2.11
Age-related susceptibility to infection with diarrheagenic Escherichia coli among infants from Periurban areas in Lima, Peru. Clin Infect Dis (2009) 2.09
Is prevalence of diarrhea a better predictor of subsequent mortality and weight gain than diarrhea incidence? Am J Epidemiol (1996) 1.95
Growing problem of multidrug-resistant enteric pathogens in Africa. Emerg Infect Dis (2007) 1.78
Early childhood diarrhea predicts impaired school performance. Pediatr Infect Dis J (2006) 1.71
Oral ciprofloxacin vs. intramuscular ceftriaxone as empiric treatment of acute invasive diarrhea in children. Pediatr Infect Dis J (2000) 1.58
Etiology of diarrhea in children younger than 5 years of age admitted in a rural hospital of southern Mozambique. Am J Trop Med Hyg (2007) 1.57
Antibiotic resistance in diarrheagenic Escherichia coli and Shigella strains isolated from children in Hanoi, Vietnam. Antimicrob Agents Chemother (2005) 1.30
Prevalence of diarrheagenic Escherichia coli in children with diarrhea in Salvador, Bahia, Brazil. Mem Inst Oswaldo Cruz (2005) 1.25
Antibiotic misuse in diarrhea. A household survey in a Mexican community. J Clin Epidemiol (1994) 1.24
Patterns of antimicrobial use and antimicrobial resistance among healthy children in Bolivia. Trop Med Int Health (1998) 1.24
Diarrheagenic Escherichia coli and Shigella strains isolated from children in a hospital case-control study in Hanoi, Vietnam. J Clin Microbiol (2008) 1.21
Antimicrobial resistance of diarrheagenic Escherichia coli isolated from children under the age of 5 years from Ifakara, Tanzania. Antimicrob Agents Chemother (1999) 1.14
Antimicrobial resistance among enteric pathogens. Semin Pediatr Infect Dis (2004) 1.11
Drug-resistant diarrheogenic Escherichia coli, Mexico. Emerg Infect Dis (2005) 1.08
Expression of the multiple antibiotic resistance operon (mar) during growth of Escherichia coli as a biofilm. J Appl Microbiol (2000) 1.07
Integron-associated antibiotic resistance in enteroaggregative and enteroinvasive Escherichia coli. Microb Drug Resist (2004) 1.00
Antimicrobial use in children under five years with diarrhea in a central region province, Thailand. Southeast Asian J Trop Med Public Health (2004) 0.96
Antibiotic resistance mechanisms among pediatric respiratory and enteric pathogens: A current update. Pediatr Infect Dis J (2006) 0.95
Infectious diarrhea: new pathogens and new challenges in developed and developing areas. Clin Infect Dis (2006) 0.91
[Antimicrobial resistance among species of Salmonella, Shigella, Escherichia, and aeromonas isolated from children with diarrhea in 7 Argentinian centers]. Rev Latinoam Microbiol (2000) 0.89
Heterogeneity among strains of diffusely adherent Escherichia coli isolated in Brazil. J Clin Microbiol (2005) 0.89
A second large plasmid encodes conjugative transfer and antimicrobial resistance in O119:H2 and some typical O111 enteropathogenic Escherichia coli strains. J Bacteriol (2007) 0.86
Antibiotic-resistant cell-detaching Escherichia coli strains from Nigerian children. J Clin Microbiol (2002) 0.86
Travelers' diarrhea: an update on susceptibility, prevention, and treatment. Curr Gastroenterol Rep (2008) 0.83
How can we achieve and maintain high-quality performance of health workers in low-resource settings? Lancet (2005) 12.16
Gaps in policy-relevant information on burden of disease in children: a systematic review. Lancet (2005) 4.64
Multi-country analysis of the effects of diarrhoea on childhood stunting. Int J Epidemiol (2008) 4.46
Setting priorities in global child health research investments: guidelines for implementation of CHNRI method. Croat Med J (2008) 3.42
Setting priorities in global child health research investments: assessment of principles and practice. Croat Med J (2007) 3.24
Environmental signatures associated with cholera epidemics. Proc Natl Acad Sci U S A (2008) 3.05
Density interactions among Streptococcus pneumoniae, Haemophilus influenzae and Staphylococcus aureus in the nasopharynx of young Peruvian children. Pediatr Infect Dis J (2013) 2.47
Detection of diarrheagenic Escherichia coli by use of melting-curve analysis and real-time multiplex PCR. J Clin Microbiol (2008) 2.11
Age-related susceptibility to infection with diarrheagenic Escherichia coli among infants from Periurban areas in Lima, Peru. Clin Infect Dis (2009) 2.09
Randomized controlled trial of the effect of daily supplementation with zinc or multiple micronutrients on the morbidity, growth, and micronutrient status of young Peruvian children. Am J Clin Nutr (2004) 1.97
Proton vs carbon ion beams in the definitive radiation treatment of cancer patients. Radiother Oncol (2010) 1.65
Peruvian Vibrio cholerae O1 El Tor strains possess a distinct region in the Vibrio seventh pandemic island-II that differentiates them from the prototype seventh pandemic El Tor strains. J Med Microbiol (2009) 1.64
Aeromonas spp. and traveler's diarrhea: clinical features and antimicrobial resistance. Emerg Infect Dis (2003) 1.60
New insights into the epidemiology of enteropathogenic Escherichia coli infection. Trans R Soc Trop Med Hyg (2008) 1.59
External (subciliary) vs internal (transconjunctival) involutional entropion repair. Am J Ophthalmol (2005) 1.58
Comparative genomic analysis of Vibrio parahaemolyticus: serotype conversion and virulence. BMC Genomics (2011) 1.56
Catecholamines, infection, and death in acute ischemic stroke. J Neurol Sci (2006) 1.49
Cholera between 1991 and 1997 in Mexico was associated with infection by classical, El Tor, and El Tor variants of Vibrio cholerae. J Clin Microbiol (2010) 1.47
Occurrence and distribution of Vibrio cholerae in the coastal environment of Peru. Environ Microbiol (2004) 1.44
Secondary carcinogenesis in patients treated with radiation: a review of data on radiation-induced cancers in human, non-human primate, canine and rodent subjects. Radiat Res (2007) 1.44
Quantitative real-time polymerase chain reaction for enteropathogenic Escherichia coli: a tool for investigation of asymptomatic versus symptomatic infections. Clin Infect Dis (2011) 1.42
Bartonella bacilliformis, endemic pathogen of the Andean region, is intrinsically resistant to quinolones. Int J Infect Dis (2009) 1.33
Wasting is associated with stunting in early childhood. J Nutr (2012) 1.33
Directing diarrhoeal disease research towards disease-burden reduction. J Health Popul Nutr (2009) 1.33
The cholera outbreak in Haiti: where and how did it begin? Curr Top Microbiol Immunol (2014) 1.31
Moderno love: sexual role-based identities and HIV/STI prevention among men who have sex with men in Lima, Peru. AIDS Behav (2013) 1.24
Diarrhea in early childhood: short-term association with weight and long-term association with length. Am J Epidemiol (2013) 1.22
Direct detection of Vibrio cholerae and ctxA in Peruvian coastal water and plankton by PCR. Appl Environ Microbiol (2003) 1.22
Evaluation of brucellosis by PCR and persistence after treatment in patients returning to the hospital for follow-up. Am J Trop Med Hyg (2007) 1.22
Epidemiology of highly endemic multiply antibiotic-resistant shigellosis in children in the Peruvian Amazon. Pediatrics (2008) 1.15
MLVA genotyping of human Brucella isolates from Peru. Trans R Soc Trop Med Hyg (2008) 1.12
A household-based study of acute viral respiratory illnesses in Andean children. Pediatr Infect Dis J (2014) 1.11
Call for global health-systems impact assessments. Lancet (2009) 1.10
Epidemiology and spectrum of disease of Escherichia coli O157. Curr Opin Infect Dis (2003) 1.10
Uric acid levels are relevant in patients with stroke treated with thrombolysis. Stroke (2010) 1.08
O3:K6 serotype of Vibrio parahaemolyticus identical to the global pandemic clone associated with diarrhea in Peru. Int J Infect Dis (2007) 1.08
Mechanism of resistance to several antimicrobial agents in Salmonella Clinical isolates causing traveler's diarrhea. Antimicrob Agents Chemother (2004) 1.07
Effect of lactoferrin on enteric pathogens. Biochimie (2008) 1.05
Long time survival of Bartonella bacilliformis in blood stored at 4 °C. A risk for blood transfusions. Blood Transfus (2012) 1.04
Lactoferrin impairs type III secretory system function in enteropathogenic Escherichia coli. Infect Immun (2003) 1.03
Molecular epidemiology of Brucella genotypes in patients at a major hospital in central Peru. J Clin Microbiol (2009) 1.00
Multimodal CT-assisted thrombolysis in patients with acute stroke: a cohort study. Stroke (2011) 0.98
Effect of lactoferrin on enteroaggregative E. coli (EAEC). Biochem Cell Biol (2006) 0.97
Human milk secretory antibodies against attaching and effacing Escherichia coli antigens. Emerg Infect Dis (2003) 0.97
Comparative safety and immunogenicity of two attenuated enterotoxigenic Escherichia coli vaccine strains in healthy adults. Infect Immun (2006) 0.97
Brucellosis in household members of Brucella patients residing in a large urban setting in Peru. Am J Trop Med Hyg (2008) 0.96
Clinical studies of lactoferrin in children. Biochem Cell Biol (2012) 0.96
Lactoferrin protects rabbits from Shigella flexneri-induced inflammatory enteritis. Infect Immun (2002) 0.96
Novel Bartonella agent as cause of verruga peruana. Emerg Infect Dis (2013) 0.96
Randomized double-blind controlled trial of bovine lactoferrin for prevention of diarrhea in children. J Pediatr (2012) 0.96
Rifaximin does not induce toxin production or phage-mediated lysis of Shiga toxin-producing Escherichia coli. Antimicrob Agents Chemother (2007) 0.95
Expression of Streptococcus pneumoniae Virulence-Related Genes in the Nasopharynx of Healthy Children. PLoS One (2013) 0.95
Factors affecting caregivers' use of antibiotics available without a prescription in Peru. Pediatrics (2013) 0.93
Immunogenicity and safety of tetravalent dengue vaccine in 2-11 year-olds previously vaccinated against yellow fever: randomized, controlled, phase II study in Piura, Peru. Vaccine (2012) 0.93
The role of influenza and parainfluenza infections in nasopharyngeal pneumococcal acquisition among young children. Clin Infect Dis (2014) 0.93
Human lactoferrin impairs virulence of Shigella flexneri. J Infect Dis (2002) 0.93
Management of children with infection-associated persistent diarrhea. Semin Pediatr Infect Dis (2004) 0.91
Impact of lactoferrin supplementation on growth and prevalence of Giardia colonization in children. Clin Infect Dis (2008) 0.91
Campylobacter antimicrobial resistance in Peru: a ten-year observational study. BMC Infect Dis (2012) 0.90
Empyema necessitans and acute osteomyelitis associated with community-acquired methicillin-resistant Staphylococcus aureus in an infant. Biomedica (2009) 0.89
Prevalence of different virulence factors and biofilm production in enteroaggregative Escherichia coli isolates causing diarrhea in children in Ifakara (Tanzania). Am J Trop Med Hyg (2008) 0.88
Concentrations of urinary 8-hydroxy-2'-deoxyguanosine and 8-isoprostane in women exposed to woodsmoke in a cookstove intervention study in San Marcos, Peru. Environ Int (2013) 0.88
Fecal leukocytes in children infected with diarrheagenic Escherichia coli. J Clin Microbiol (2011) 0.88
Multiplex real-time PCR (MRT-PCR) for diarrheagenic. Methods Mol Biol (2013) 0.88
Facilitated molecular typing of Shigella isolates using ERIC-PCR. Am J Trop Med Hyg (2012) 0.87
Outcomes of serial dilation for high-grade radiation-related esophageal strictures in head and neck cancer patients. Laryngoscope (2014) 0.87
[Frequency and pathotypes of diarrheagenic Escherichia coli in Peruvian children with and without diarrhea]. Rev Peru Med Exp Salud Publica (2011) 0.87
Carbon monoxide exposures and kitchen concentrations from cookstove-related woodsmoke in San Marcos, Peru. Int J Occup Environ Health (2013) 0.86
Cost-effectiveness of rotavirus vaccination in peru. J Infect Dis (2009) 0.85
Primary human hepatocyte culture for HCV study. Methods Mol Biol (2009) 0.85
Effects of Shigella-, Campylobacter- and ETEC-associated diarrhea on childhood growth. Pediatr Infect Dis J (2014) 0.85
Molecular mechanisms of antibiotic resistance in diarrhoeagenic Escherichia coli isolated from children. Int J Antimicrob Agents (2012) 0.83
Fecal contamination of food, water, hands, and kitchen utensils at the household level in rural areas of Peru. J Environ Health (2014) 0.83
Class 1 Integrons in Salmonella Strains causing traveler's diarrhea. Antimicrob Agents Chemother (2006) 0.83